Molecular Markers Guiding Thyroid Cancer Management
The incidence of thyroid cancer is rapidly increasing, mostly due to the overdiagnosis and overtreatment of differentiated thyroid cancer (TC). The increasing use of potent preclinical models, high throughput molecular technologies, and gene expression microarrays have provided a deeper understandin...
Main Authors: | Carolina Nylén, Robert Mechera, Isabella Maréchal-Ross, Venessa Tsang, Angela Chou, Anthony J. Gill, Roderick J. Clifton-Bligh, Bruce G. Robinson, Mark S. Sywak, Stan B. Sidhu, Anthony R. Glover |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-08-01
|
Series: | Cancers |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6694/12/8/2164 |
Similar Items
-
Indeterminate thyroid nodules in the era of molecular genomics
by: Sarika N. Rao, et al.
Published: (2020-09-01) -
Ultrasound elastography in the diagnostic evaluation of indeterminate thyroid nodule
by: Sherif Fathy Abdelrahman, et al.
Published: (2015-09-01) -
Approaching indeterminate thyroid nodules in the absence of molecular markers: “The BETH-TR score”
by: Sushma Mehta, et al.
Published: (2020-01-01) -
Can current molecular tests help in the diagnosis of indeterminate thyroid nodule FNAB?
by: Carolina Ferraz -
The Combination of Sonographic Features and the Seven-Gene Panel May be Useful in the Management of Thyroid Nodules With Indeterminate Cytology
by: Marco Capezzone, et al.
Published: (2021-02-01)